Technical Indicators and Signals
The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Neogenomics Inc. (NASDAQ:NEO) for the period of 9-Day stands at 13.67% while the stochastic %D for the same period stands at 19.59%.
The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Neogenomics Inc. (NASDAQ:NEO) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.
Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Neogenomics Inc. (NASDAQ:NEO) while 20-100 Day MACD Oscillator indicates “Buy”.
Bollinger band is a volatility indicator of a certain security, currently Neogenomics Inc. (NASDAQ:NEO)’s 20-Day Bollinger Band indicates “Sell”.
NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company’s testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, hospitals and other reference laboratories throughout the United States.
Previous Day Activity Analysis
On the last trading day, Neogenomics Inc. (NASDAQ:NEO) opened the session at $9.49 and after going down -6.15% closed at $8.93. The stock lost -0.56 points in the last trade.
Neogenomics Inc. (NASDAQ:NEO)’s stock fluctuated in the range of $8.70 and $9.49 during the previous active session. Neogenomics Inc. (NASDAQ:NEO) traded with the volume of 643997 with average volume of 363.25 Million. The stock has HIGH volatility on the last trading session.
Currently the Beta for the company remains at 0.92 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.47 and 25.9 respectively.
Currently the Insider Ownership of the shares of Neogenomics Inc. (NASDAQ:NEO) is at 4.5% and the shares outstanding are 93.47 Million.
Important Ratio Analysis
Some important ratios to consider here for Neogenomics Inc. (NASDAQ:NEO) are discussed below:
Dividend yield of Neogenomics Inc. (NASDAQ:NEO) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 33.2.
The Price to Sale P/S and Price to Book P/B shows the value of 3.35 and 4.19 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 76.58 and 379.4 correspondingly.
The Quick Ratio of Neogenomics Inc. (NASDAQ:NEO) stands at 2.2 while the Current Ratio depicts the value of 2.4.
Return on Assets ROA of Neogenomics Inc. (NASDAQ:NEO) is at -7.5% whereas, Return on Equity ROE and Return of Investment ROI of Neogenomics Inc. (NASDAQ:NEO) stand at -14.7% and 1.6% respectively.
Stock Performance Analysis
The stock performance of Neogenomics Inc. (NASDAQ:NEO) on the basis of 5 day trade show the dip of -19.84% whereas, the monthly performance of the stock shows decrease of -17.39%.
The quarterly performance of the stock remained in red zone with the value of -2.83% while six month performance of the shares of Neogenomics Inc. (NASDAQ:NEO) remained bullish with the count of 6.82%.
The yearly and YTD performance of Neogenomics Inc. (NASDAQ:NEO) remained up at 18.91% and 4.2% respectively.